About Nuclear factor 1 X-type
Nuclear factor 1 X-type (NFIX) is a protein
from Homo sapiens identified by UniProt accession
Q14938, 502 residues long.
MolForge cross-references it against 0 known binders and
297 disease associations.
Target properties
| Protein name | Nuclear factor 1 X-type |
| UniProt accession | Q14938 |
| Gene | NFIX |
| Organism | Homo sapiens |
| Length | 502 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (297)
Diseases linked to this target (Open Targets).
- Malan overgrowth syndrome · score 0.80
- Marshall-Smith syndrome · score 0.79
- Sotos syndrome · score 0.57
- genetic disorder · score 0.51
- cortical surface area measurement · score 0.39
- craniosynostosis · score 0.38
- neuroimaging measurement · score 0.37
- lymphocyte count · score 0.36
- brain measurement · score 0.34
- cortical thickness · score 0.34
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14938-F1 | alphafold | PREDICTED | 61.62 | — |
Amino-acid sequence (502 residues)
MYSPYCLTQD EFHPFIEALL PHVRAFSYTW FNLQARKRKY FKKHEKRMSK DEERAVKDEL LGEKPEIKQK WASRLLAKLR KDIRPEFRED FVLTITGKKP PCCVLSNPDQ KGKIRRIDCL RQADKVWRLD LVMVILFKGI PLESTDGERL YKSPQCSNPG LCVQPHHIGV TIKELDLYLA YFVHTPESGQ SDSSNQQGDA DIKPLPNGHL SFQDCFVTSG VWNVTELVRV SQTPVATASG PNFSLADLES PSYYNINQVT LGRRSITSPP STSTTKRPKS IDDSEMESPV DDVFYPGTGR SPAAGSSQSS GWPNDVDAGP ASLKKSGKLD FCSALSSQGS SPRMAFTHHP LPVLAGVRPG SPRATASALH FPSTSIIQQS SPYFTHPTIR YHHHHGQDSL KEFVQFVCSD GSGQATGQPN GSGQGKVPGS FLLPPPPPVA RPVPLPMPDS KSTSTAPDGA ALTPPSPSFA TTGASSANRF VSIGPRDGNF LNIPQQSQSW FL
Explore Nuclear factor 1 X-type with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets